These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38113075)

  • 21. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo generation of multi-target compounds using deep generative chemistry.
    Munson BP; Chen M; Bogosian A; Kreisberg JF; Licon K; Abagyan R; Kuenzi BM; Ideker T
    Nat Commun; 2024 May; 15(1):3636. PubMed ID: 38710699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.
    Zhao Z; Xie L; Xie L; Bourne PE
    J Med Chem; 2016 May; 59(9):4326-41. PubMed ID: 26929980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.
    Al-Ali H; Lee DH; Danzi MC; Nassif H; Gautam P; Wennerberg K; Zuercher B; Drewry DH; Lee JK; Lemmon VP; Bixby JL
    ACS Chem Biol; 2015 Aug; 10(8):1939-51. PubMed ID: 26056718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
    Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
    Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-reactivity virtual profiling of the human kinome by X-react(KIN): a chemical systems biology approach.
    Brylinski M; Skolnick J
    Mol Pharm; 2010 Dec; 7(6):2324-33. PubMed ID: 20958088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AI for targeted polypharmacology: The next frontier in drug discovery.
    Cichońska A; Ravikumar B; Rahman R
    Curr Opin Struct Biol; 2024 Feb; 84():102771. PubMed ID: 38215530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacology-based ceritinib repurposing using integrated functional proteomics.
    Kuenzi BM; Remsing Rix LL; Stewart PA; Fang B; Kinose F; Bryant AT; Boyle TA; Koomen JM; Haura EB; Rix U
    Nat Chem Biol; 2017 Dec; 13(12):1222-1231. PubMed ID: 28991240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery.
    Manen-Freixa L; Antolin AA
    Expert Opin Drug Discov; 2024 Sep; 19(9):1043-1069. PubMed ID: 39004919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A community challenge for a pancancer drug mechanism of action inference from perturbational profile data.
    Douglass EF; Allaway RJ; Szalai B; Wang W; Tian T; Fernández-Torras A; Realubit R; Karan C; Zheng S; Pessia A; Tanoli Z; Jafari M; Wan F; Li S; Xiong Y; Duran-Frigola M; Bertoni M; Badia-I-Mompel P; Mateo L; Guitart-Pla O; Chung V; ; Tang J; Zeng J; Aloy P; Saez-Rodriguez J; Guinney J; Gerhard DS; Califano A
    Cell Rep Med; 2022 Jan; 3(1):100492. PubMed ID: 35106508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Polypharmacological Profiles by Affinity Fingerprinting.
    Peragovics A; Simon Z; Malnasi-Csizmadia A; Bender A
    Curr Pharm Des; 2016; 22(46):6885-6894. PubMed ID: 27587199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea-based antineoplastic kinase inhibitors.
    Dokla EM; Mahmoud AH; Elsayed MS; El-Khatib AH; Linscheid MW; Abouzid KA
    PLoS One; 2012; 7(11):e49284. PubMed ID: 23185312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-target-based polypharmacology prediction (mTPP): An approach using virtual screening and machine learning for multi-target drug discovery.
    Liu K; Chen X; Ren Y; Liu C; Lv T; Liu Y; Zhang Y
    Chem Biol Interact; 2022 Dec; 368():110239. PubMed ID: 36309139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The target landscape of clinical kinase drugs.
    Klaeger S; Heinzlmeir S; Wilhelm M; Polzer H; Vick B; Koenig PA; Reinecke M; Ruprecht B; Petzoldt S; Meng C; Zecha J; Reiter K; Qiao H; Helm D; Koch H; Schoof M; Canevari G; Casale E; Depaolini SR; Feuchtinger A; Wu Z; Schmidt T; Rueckert L; Becker W; Huenges J; Garz AK; Gohlke BO; Zolg DP; Kayser G; Vooder T; Preissner R; Hahne H; Tõnisson N; Kramer K; Götze K; Bassermann F; Schlegl J; Ehrlich HC; Aiche S; Walch A; Greif PA; Schneider S; Felder ER; Ruland J; Médard G; Jeremias I; Spiekermann K; Kuster B
    Science; 2017 Dec; 358(6367):. PubMed ID: 29191878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategy toward Kinase-Selective Drug Discovery.
    Zhang M; Liu Y; Jang H; Nussinov R
    J Chem Theory Comput; 2023 Mar; 19(5):1615-1628. PubMed ID: 36815703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AiKPro: deep learning model for kinome-wide bioactivity profiling using structure-based sequence alignments and molecular 3D conformer ensemble descriptors.
    Park H; Hong S; Lee M; Kang S; Brahma R; Cho KH; Shin JM
    Sci Rep; 2023 Jun; 13(1):10268. PubMed ID: 37355672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An up-to-date overview of computational polypharmacology in modern drug discovery.
    Chaudhari R; Fong LW; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2020 Sep; 15(9):1025-1044. PubMed ID: 32452701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KiSSim: Predicting Off-Targets from Structural Similarities in the Kinome.
    Sydow D; Aßmann E; Kooistra AJ; Rippmann F; Volkamer A
    J Chem Inf Model; 2022 May; 62(10):2600-2616. PubMed ID: 35536589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors.
    Joisa CU; Chen KA; Berginski ME; Golitz BT; Jenner MR; Herrera Loeza G; Yeh JJ; Gomez SM
    PeerJ; 2023; 11():e16342. PubMed ID: 38025707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.